Newsroom-Katalog
Zeit | RHEACELL GmbH und Co. KG: Meldungen vom 19.12.2024 |
---|---|
11:12 | RHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers |
Zeit | RHEACELL GmbH und Co. KG: Meldungen vom 19.12.2024 |
---|---|
11:12 | RHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers |